According to a 2016 ISR survey, 80% of respondents stated that Phase I studies are becoming more complex and 90% plan to increase the number of sites for early stage trials. To compete, sponsors continually search for opportunities to contain costs while addressing increasingly unique study needs and pressure to shorten timelines.

In this webinar, you’ll explore how to simplify and streamline Phase I and IIa study execution through clinical technology, including:

  • Implementing a cost-effective, pre-configured and pre-packaged solution for early phase trials
  • Making a rapid transition from early stage to Phase IIb / III, where needs scale to include more sites, larger patient pools and more complex study designs
Register today and discover how early-stage solutions can give you the competitive edge you need to accelerate your clinical development lifecycle.

Featured Speaker

Theresa Barnott

Manager, Implementation Consulting
Medidata Solutions

Theresa has over 15 years experience working in the Pharmaceutical/Life Sciences industry, with 10 years experience designing and building EDC and related systems across all phases and therapeutic areas. She is a Manager of Implementation Consulting at Medidata, and her area of expertise is Phase 1, and Oncology study design.

Date:  Wednesday, June 20, 2018
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar